News
Introducing our hiEX™ Research iPSC Exosomes For powering next-generation regenerative medicine research June 24, 2025 11:00 AM PST Meet our hiEX™ Research iPSC Exosomes, a new research-use-only product designed to enable
Our two new hypoimmunogenic hiPSC products are here to accelerate your allogeneic therapies May 20, 2025 8:30 AM PST We are thrilled to announce the launch of our first hypoimmunogenic
Announcing our Drug Master File Submission to the US FDA for our GMP-Grade iPSC Cell Line April 14, 2025 12:00 PM PST We are thrilled to announce that we have
Applied StemCell’s Brand Refresh: Building the biology-based future January 30, 2025 12:00 PM PST Drug discovery is a famously challenging endeavor, with a 96% failure rate, a $1B+ price tag
January 14, 2025 9:00 AM PST Milpitas, California, January 2025 – Applied StemCell, Inc., a proven CRO/CDMO and gene editing technology developer, is pleased to welcome Todd Garland to our
October 01, 2024 10:00 AM PST MILPITAS, Calif. – Applied StemCell, Inc. is proud to announce the successful approval of its latest U.S. patent which covers HLA-F engineered universal
